<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-599
Date of Submission: 2025-02-27

This report was submitted by a Other Healthcare Professional from Campbell-Smith Medical Center concerning patient ANON-PX-8910. The subject is a 53-year-old other with a significant medical history including migraines, type 2 diabetes. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Intramuscular route at a dosage of 327mg, initiated on 2025-01-24 for Neuropathic pain and discontinued on 2025-02-23.

On approximately 2025-02-09, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Somnolence, Headache, Vomiting, Stevens-Johnson syndrome. The Somnolence was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Headache was classified as Severe in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Unknown'. The Vomiting was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Stevens-Johnson syndrome was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed understand and advised book. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 7 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Hope product plan economic city.</data>
report_id: ADR-2025-599
report_date: '2025-02-27'
patient_details:
  patient_id: ANON-PX-8910
  gender: Other
  relevant_history:
  - migraines
  - type 2 diabetes
  age_at_reaction: 53
suspected_drugs:
- drug_name: Gabapentin
  dosage: 327mg
  route_of_administration: Intramuscular
  start_date: '2025-01-24'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2025-02-23'
adverse_reactions:
- symptom_name: Somnolence
  onset_date: '2025-02-09'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: false
- symptom_name: Headache
  onset_date: '2025-02-09'
  severity: Severe
  outcome: Unknown
  intervention_required: true
- symptom_name: Vomiting
  onset_date: '2025-02-09'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: false
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-02-09'
  severity: Severe
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed understand and advised book.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
  naranjo_score: 7
reporting_facility: Campbell-Smith Medical Center
reporter_type: Other Healthcare Professional
notes: Hope product plan economic city.
